
pmid: 34301779
pmc: PMC8612335
Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.
Radioisotopes, 3202 Clinical sciences, 1103 Clinical Sciences, production and supply of radionuclides, targeted α-therapy, Alpha Particles, Nuclear Medicine & Medical Imaging, 227Th/223Ra, Humans, 211At, Radiopharmaceuticals, 212Pb/212Bi, 225Ac/213Bi
Radioisotopes, 3202 Clinical sciences, 1103 Clinical Sciences, production and supply of radionuclides, targeted α-therapy, Alpha Particles, Nuclear Medicine & Medical Imaging, 227Th/223Ra, Humans, 211At, Radiopharmaceuticals, 212Pb/212Bi, 225Ac/213Bi
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 108 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
